References
Littlejohns P, Macdonald LD. The relationship between severe asthma and social class. Resp Med 1993; 87: 139–43
Strachan DP, Anderson HR, Limb ES et al. A national survey of asthma prevalence, severity and treatment in Great Britain. Arch Dis Child 1994; 70: 174–8
Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication. Does combining beta agonist with corticosteroids improve compliance? Eur Respir J 1994; 7: 504–9
Dompeling E, van Grunsven PM, van Schayck CP, et al. Treatment with inhaled steroids in asthma and chronic bronchitis: long term compliance and inhaler technique. Farn Pract 1992; 9: 161–6
Dekker FW, Dieleman FE, Kaptein AA, et al. Compliance with pulmonary medication in general practice. European Respiratory Journal 1993; 6: 886–90
Osman LM, Abdalla MI, Beattie JAG, et al. Reducing hospital admission through computer supported education for asthma patients. BMJ 1994; 308: 568–71
Charlton I, Charlton G, Broomfield J. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ 1990; 301; 1355–9
Wilson SR, Scamagas P, German DF, et al. A controlled trial of two forms of self-management education for adults with asthma. Am J Med 1993; 94: 564–76
Mayo PH, Richman J, Harris HW. Results of a program to reduce admission for adult asthma. Ann Intern Med 1990; 112: 864–71
Yoon R, McKenzie DK, Bauman A, et al. Controlled trial evaluation of an asthma education programme for adults. Thorax 1993; 48: 1110–6
Ignacio-Garcia JM, Gonzalez-Santos P. Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med 1995; 151 (Pt 1); 353–9
Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ 1996; 312: 748–52
Jones KP, Mullee MA. Proactive nurse run care in general practice reduces asthma morbidity: scientific fact or medical assumption? British Journal of General Practice. 1995; 45: 497–9
Neville RG, Clark RC, Hoskins G, et al. National asthma attack audit 1991-2. General Practitioners in Asthma Group. BMJ 1993; 306: 559–62
Dompeling E, van Schayck CP, van Grunsven PM, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993; 118(10): 770–8
van Schayck CP, Dompeling E, Rutten MPMH, et al. The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest 1995; 107: 1199–205
Rutten MPMH, Custers F, van Doorslaer EKA, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995; 8: 888–98
Spector SL. Management of asthma with zafirlukast. Clinical experience and tolerability profile. Drugs 1996; 52 Suppl. 6: 36–46
Barnes NC, Black B, Syrett N, et al. Reduction of exacerbations of asthma in multi-national clinical trials with zafirlukast (Accolate™;) [abstract]. Allergy 1996; 51 Suppl. 30: 84
Rights and permissions
About this article
Cite this article
Questions and Answers. Drugs 52 (Suppl 6), 47–55 (1996). https://doi.org/10.2165/00003495-199600526-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199600526-00008